Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains

Molecular Brain Research

Volumn 41, Issue 1-2, 1996, Pages 36-49

  Norris, Paula J ^a   Faull, Richard L M ^b   Emson, Piers C ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Alzheimer's disease; Cerebral cortex; Excitotoxicity; Hippocampus; Hybridisation; In situ; NADPH diaphorase histochemistry; Neuronal nitric oxide synthase

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SULFUR 35;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; ENZYME HISTOCHEMISTRY; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; VISUAL CORTEX; WHITE MATTER;

EID: 0040510653     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(96)00064-2     Document Type: Article

References (46)

1. Ang L.-C., Shul D.D. Peptidergic neurons of subcortical white matter in aging and Alzheimer's disease. Brain Res. 674:1995;329-335.
2. Augood S.J., Herbison A.E., Emson P.C. Localization of GAT-1 GABA transporter mRNA in rat striatum: cellular coexpression with GAD67 mRNA, GAD67 immunoreactivity, and parvalbumin mRNA. J. Neurosci. 15:1995;865-874.
3. Beal M.F., Kowall N.W., Swartz K.J., Ferrante R.J., Martin J.B. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse. 3:1989;38-47.
4. Beal M.F., Mazurek M.F., Chattha G.K., Svensden C.N., Bird E.D., Martin J.B. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease. Ann. Neurol. 20:1986;282-288.
5. Beal M.F., Mazurek M.F., Svensden C.N., Bird E.D., Martin J.B. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease. Ann. Neurol. 20:1986;489-486.
6. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:1990;682-685.
7. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
8. Cajal, S.R., Histologie du Systeme Neerveux de l'Homme et des Vertebres. Malonine, Paris, (1911 (reprinted Madrid, 1952)).
9. Candy J.M., Cascoigne A.D., Biggins J.A., Smith A.I., Perry R.H., McDermott J.R., Edwardson J.A. Somatostatin immunoreactivity in cortical and some sub-cortical regions in Alzheimer's disease. J. Neurol. Sci. 71:1985;315-323.
10. Chan-Palay V. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia. J. Comp. Neurol. 260:1987;201-223.
11. Chan-Palay V., Lang W., Allen Y.S., Haesler U., Polak J.M. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's type dementia. J. Comp. Neurol. 238:1985;390-400.
12. Choi D.W. Nitric oxide: foe or friend to the injured brain? Proc. Natl. Acad. Sci. USA. 90:1993;9741-9743.
13. Chun J.J.M., Shatz C.J. Interstitial cells of the adult neocortical white matter are the remnant of the early generated subplate neuron population. J. Comp. Neurol. 282:1989;555-569.
14. Davies P., Katzman R., Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer senile dementia. Nature. 288:1980;279-280.
15. Dawbarn D., Rossor M.N., Mountjoy C.Q., Roth M., Emson P.C. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type. Neurosci. Lett. 70:1986;154-159.
16. Dawson T.M., Bredt D.S., Fotuhi M., Hwang P.M., Snyder S.H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. USA. 88:1991;7797-7801.
17. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
18. Dournaud P., Cervera-Pierot P., Hirsch E., Javoy-Agig F., Kordon C.L., Agid Y., Epelbaum J. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex. Neuroscience. 61:1994;755-764.
19. Emson, P.C., Augood, S.J., Senaris, R., Guevara Guzman, R., Kishimoto, J., Kadowaki, K., Norris, P.J. and Kendrick, K.M., Chemical signalling in striatal interneurones. In: G.W. Arbuthnot and P.C. Emson (Eds.), Chemical Signalling in the Basal Ganglia. Prog. in Brain Research, 1993, pp. 155-166.
20. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 230:1985;561-563.
21. Fischer H.C., Kuljis R.O. Multiple types of nitrogen monoxide synthase-/NADPH diaphorase-containing neurons in the human cerebral neocortex. Brain Res. 654:1994;105-117.
22. Gabriel S.M., Bierer L.M., Harotunianm V., Purohit D.P., Perl D.P., Davis K.L. Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex. Neurosci. Lett. 155:1993;116-120.
23. Gaspar P., Duyckaerts C., Febvret A., Benoit R., Beck B., Berger B. Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type. Brain Res. 490:1989;1-13.
24. Hope B.T., Michael G.J., Knigge K.M., Vincent S.R. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natn. Acad. Sci. USA. 88:1991;2811-2814.
25. Hyman B.T., Marszloff K., Wenniger J.J., Dawson T.M., Bredt D.S., Snyder S.H. Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann. Neurol. 32:1992;818-820.
26. Kingsbury A.E., Foster O.J.F., Nisbet A.P., Cairns N., Bray L., Eve D.J., Lees A.J., Marsden C.D. Tissue pH as an indicator of mRNA preservation in human postmortem brain. Mol. Brain Res. 28:1995;311-318.
27. Kowall N.W., Beal M.F. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease. Ann. Neurol. 23:1988;105-114.
28. Kowall N.W., Ferrante R.J., Beal M.F., Richardson E.P., Sofroniew M.V., Cuello A.C., Martin J.B. Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: a combined immunocytochemical and enzyme histochemical study. Neuroscience. 20:1987;817-828.
29. Lipton S.A., Choi Y.-B., Pan Z.-H., Lei S.Z., Chen H.-S.V., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
30. Mufson E.J., Brady D.R., Carey R.G. Reduced nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d) histochemistry in the hippocampal formation of the new world monkey (Saimiri sciureus). Brain Res. 516:1990;237-247.
31. Nakamura S., Kawamata T., Akiguchi I., Kameyama M., Kimura H. Reduced nicotinamide adenine dinucleotide phosphate diaphorase histochemistry in neocortex and hippocampus in patients with Alzheimer type dementia and aged controls. Clin. Neurol. 27:1987;1059-1063.
32. Norris P.J., Hardwick J.P., Emson P.C. Localization of NADPH cytochrome P450 oxidoreductase in rat brain by immunohistochemistry and in situ hybridization and a comparison with the distribution of neuronal NADPH-diaphorase staning. Neuroscience. 61:1994;331-350.
33. Norris P.J., Hardwick J.P., Emson P.C. Studies on the localisation and expression of nitric oxide synthase using histochemical techniques. Histochem. J. 27:1995;745-756.
34. Norris P.J., Waldvogel H., Faull R.L.M., Emson P.C. Decreased nitric oxide synthase mRNA expression and immunoreactivity in the striatum of pathologically graded cases of Huntington's disease. Neuroscience. 72:1996;1037-1047.
35. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
36. Rebeck G.W., Marzloff K., Hyman B.T. The pattern of NADPH-diaphorase staining, a marker of nitric oxide synthase activity, is altered in the perforant pathway terminal zone in Alzheimer's disease. Neurosci. Lett. 152:1993;165-168.
37. Rosser M.N., Emson P.C., Mountjoy C.Q., Roth M., Iversen L. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer's type. Neurosci. Lett. 20:1980;373-377.
38. Salin P., Mercugliano M., Chesselet M.-F. Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat. Cell. Mol. Neurobiol. 10:1990;127-144.
39. Selden N., Geula C., Hersh L., Mesulam M.-M. Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimers disease. Neuroscience. 60:1994;621-636.
40. Siegel, S., Nonparametric Statistics for the Behavioral Sciences, McGraw-Hill, New York, 1956.
41. Sobreviela T., Mufson E.J. Reduced nicotinamide adenine dinucleotide phosphate-diaphorase/nitric oxide synthase profiles in the human hippocampal formation and the perirhinal cortex. J. Comp. Neurol. 358:1995;440-464.
42. Uemura Y., Kowall N.W., Beal M.F. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann. Neurol. 27:1990;620-625.
43. Unger J.W., Lange W. NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer's disease. Acta Neuropathol. 83:1992;636-646.
44. Vincent S.R., Hope B.T. Neurons that say NO. Trends Neurosci. 15:1992;108-113.
45. Vincent S.R., Johansson O. Striatal neurons containing both somatostatin and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH diaphorase activity: a light and electron microscopic study. J. Comp. Neurol. 217:1983;264-270.
46. Vincent S.R., Johansson O., Hokfelt T., Skirboll L., Elde R.P., Terenius L., Kimmel J., Goldstein M. NADPH diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin and avian pancreatic polypeptide (APP)-like immunoreactivities. J. Comp. Neurol. 217:1983;252-263.